Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › Disease Areas › Cancer › Persephone Biosciences Launches Study to Assess Microbiome's Role in Cancer Treatment Response

Persephone Biosciences Launches Study to Assess Microbiome's Role in Cancer Treatment Response

Nov 24, 2020
|
staff reporter

NEW YORK – Persephone Biosciences on Monday announced the launch of an observational study to assess the microbiome's effect on cancer patients' immune function and response to treatment.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Apr
27
Featured Webinar

Oncology in the Time of COVID-19: Quantitative Proteomic Analysis of Anti-IL6 Treated Patients

Sponsored by
Biognosys

This webinar, the first in our Next-Generation Proteomics for Precision Oncology series, will discuss how proteomics can help overcome the challenges of treating COVID-19 patients with oncologic comorbidities.

Jun
16
Featured Webinar

Precision Oncology in Melanoma Patients Treated with Immunotherapy: Clinical and Technological Perspective

Sponsored by
Biognosys

This webinar, the second in our Next-Generation Proteomics for Precision Oncology series, will discuss how unbiased discovery proteomics can be used to identify new key mechanisms and signatures supporting clinical decision-making for melanoma patients.

What's Popular?

In Cancer

  1. In Brief This Week: Gilead Sciences, Atossa Therapeutics, Karmanos Cancer Institute

  2. Immunocore's Tebentafusp Prolongs Survival in Uveal Melanoma Patients, AACR Study Shows

    Premium

  3. Celcuity Licenses PI3K/mTOR Inhibitor from Pfizer, Enters $25M Debt Financing Agreement

  4. With Support From Lawmakers, WGS Becoming More Accessible to Netherlands' Cancer Patients

    Premium

  5. Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.